Ainos, Inc. announced that it has launched its VELDONA Pet cytoprotein health supplements. VELDONA Pet will first be marketed in Taiwan in June, with near-term plans to expand sales and marketing in other markets. Multiple new VELDONA Pet products are in the works.

Ainos targets approximately USD 20 million in revenues from VELDONA Pet during 2024, boosted by its growing product portfolio and expansion into new markets. With approximately one in four Taiwanese families now owning pets, Taiwan is the ideal location for product launch. There are currently around three million pet dogs and cats in Taiwan, surpassing the number of children under 14 years old, and this number is projected to grow to four million by 2025.

Based on Ainos' low-dose oral interferon-alpha ("IFNa") formulation, VELDONA®? Pet supplements are backed by numerous research studies and clinical trials, and are manufactured with world-class materials in a highly certified food-grade plant. VELDONA®?

maintains immunity and contributes to gum and skin health, relieving diseases and reducing stress in cats and dogs. Interferon is naturally produced by an organism's body. When cells are invaded by foreign particles, immune signaling molecules notify neighboring cells.

Once neighboring cells receive the interferon's protein signal through their surface receptors, they initiate and modulate the immune system to protect felines and canines from gum and skin diseases, allergies, and stress-related conditions. A clinical study, sponsored by Ainos and conducted by the state-of-the-art Agricultural Technology Research Institute, has demonstrated that VELDONA® helps maintain the immune systems of cats and dogs. Numerous studies have reported the benefits of interferons in maintaining gum health and skin health, relieving discomfort caused by allergies, and soothing emotional stress in cats and dogs.

VELDONA® Pet not only provides protection against common and hard-to-diagnose diseases including feline chronic gingivostomatitis (FCGS), a severe oral mucosal inflammatory disease afflicting cats, and canine atopic dermatitis (CAD), an inflammatory skin disease found in dogs, but also offers the safest and highest quality products on the market.